𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alendronate for osteoporosis in men with androgen-repleted hypogonadism

✍ Scribed by Ilan Shimon; Varda Eshed; Ram Doolman; Ben-Ami Sela; Avraham Karasik; Iris Vered

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
250 KB
Volume
16
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Osteoporosis in men with prostate carcin
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy : Recommendations for diagnosis and therapies
✍ Terrence H. Diamond; Celestia S. Higano; Matthew R. Smith; Theresa A. Guise; Fre πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Androgen‐deprivation therapy (ADT) is prescribed with increasing frequency for men with prostate carcinoma. There is growing concern about the effects of such therapy on the skeleton. In the current review, the authors addressed the current research, diagnostic methods, a

Is androgen substitution necessary in hy
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
✍ Pavlidis, Nicholas ;Nikolaou, Nikitas ;Tolis, Christos ;Orfanos, Stylianos ;Toli πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 368 KB

A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described. Chemotherapy administration caused prolonged and life-threatening myelosuppression; androgen substitution seemed to reverse bone marrow function a